AAlyntStartup status intelligence
Explore
Enterprise AIConfidence BUnited Statesactive

Enveda Biosciences

AI drug discovery company using machine learning to identify medicines from natural chemistry.

Official websiteenveda.com
RegionBoulder, United States
CategoryEnterprise AI
Funding statusSeries C · Undisclosed
Last updatedJun 11, 2026
Latest signalJun 11, 2026
WebsiteSubmit correction

Status timeline

Funding, product, customer, team, and correction signals
Fact record
Apr 1, 2024Confidence A
Product0 evidence links

Enveda Biosciences product scope reviewed

Enveda Biosciences public product source reviewed for category placement and current operating focus.

No source evidence matched to this event.
Apr 1, 2024Confidence A
Funding0 evidence links

Enveda Biosciences capital or status signal reviewed

Enveda Biosciences public source reviewed for capital or strategic-status timeline signal.

No source evidence matched to this event.

Funding timeline

Amounts are shown only when disclosed and tied to evidence.
Fact record
Apr 1, 2024

Series C

AmountUndisclosed
InvestorsDimension, Kinnevik
EvidenceConfidence A
No source evidence matched to this round.

Source evidence

Public links, short factual summaries, and trust levels
Fact record

Enveda Biosciences capital or status signal

Enveda Biosciences · official
Confidence A

Enveda Biosciences public capital or strategic-status source reviewed for stage and timeline signal.

Trust APublic review
Open source

Enveda Biosciences official product profile

Enveda Biosciences official site · official
Confidence A

Enveda Biosciences official source reviewed for product scope, operating focus, and category placement.

Trust APublic review
Open source

Similar projects

Same category or overlapping tags
Discovery
Xaira TherapeuticsSeries A · AI drug discovery, biotechGenesis TherapeuticsSeries B · AI drug discovery, biotechPathAISeries C · life sciences, medical AITianrang IntelligenceSeries B · decision intelligence, enterprise AI